Delivery Order SPE2DB22D1106-SPE2DB25FFAK7
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Trokendi XR 100 mg capsules (30-count packages) with a ceiling value of $3,379.08. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by September 22, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 30, 2025, for the supply of Trokendi XR 25 mg capsules (30-count) valued at $1,476.35. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is scheduled for completion by May 1, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $1,309.32 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Trokendi XR 25 mg capsules (30-count package). This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of September 17, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $29,860.13 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Trokendi XR 200 mg capsules (30-count units). The award was made without a set-aside designation through open competition. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform at its corporate office location. This delivery order represents a child contract action under the...
- The Defense Logistics Agency awarded a delivery order valued at $11,571.94 to AmerisourceBergen Drug Corp for the supply of Trokendi XR 200 mg capsules (30-count units) under a firm fixed price contract. The delivery order, issued on August 6, 2025, with an ultimate completion date of August 7, 2025, represents a non-set-aside award to the prime contractor. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 29, 2025, for the supply of Trokendi XR 200 mg capsules (30-count units) with a ceiling value of $12,939.63. This is a firm fixed-price delivery order with no set-aside designation, indicating the award resulted from open competition. The contract is set to be completed by April 30, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,969.00 fixed-price delivery order is for the supply of Trokendi XR 100 mg capsules to support federal healthcare programs. The contract has an ultimate completion date of February 7, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has received a firm fixed price delivery order for $2,004.30 from the Defense Logistics Agency (DLA) Troop Support Medical program. The order is to supply 4562729710 Trokendi XR 100mg capsules, 30 count, with performance at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania by November 7, 2023. No set-aside designation was used for this award issued against an indefinite delivery contract held by...
- The Defense Logistics Agency awarded a $1,144.20 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 50mg Trokendi XR capsules. Under this single award, Amerisourcebergen will deliver 30 capsules to a facility in Conshohocken, Pennsylvania by August 9th, 2023, fulfilling DLA's requirement for this pharmaceutical product. As the prime contractor, Amerisourcebergen will perform the order itself without involvement of major subcontractors. This delivery order was issued...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Trokendi XR 50 mg capsules (30-count) with a ceiling value of $2,995.93. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by September 8, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFAK7Delivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on July 29, 2025, for the supply of Trokendi XR 50 mg capsules (30-count package) with a ceiling value of $2,832.68. This firm fixed-price delivery order, with an ultimate completion date of July 30, 2025, represents a competitive award with no set-aside designation. The contract is performed at the company's corporate office location in Conshohocken, Pennsylvania, and falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This delivery order is part of AmerisourceBergen's comprehensive pharmaceutical supply portfolio for federal military healthcare programs. The DLA Medical Supply Chain utilizes AmerisourceBergen as a critical vendor for neurological, pain management, and specialty pharmaceutical products supporting Defense Health Agency operations and other federal healthcare systems. The pharmaceutical prime vendor vehicle enables AmerisourceBergen to fulfill diverse medical supply requirements across multiple therapeutic domains for military personnel and veterans worldwide, demonstrating the company's established capability to meet federal procurement standards through competitive processes and reliable delivery of brand-name medications.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 7/29/25 |